ENTITY

Grace Therapeutics (GRCE US)

Analysis

Health Care • United States

Grace Therapeutics, Inc. operates as a late-stage biopharma company. The Company focuses on drug delivery and technologies addressing rare and orphan diseases. Grace Therapeutics serves clients in Canada and the United States.

Refresh

Exchange Announcement • 13 Nov 2024 21:00

Current Report (Form 8-K | Period ending 2024-11-13)

Exchange Announcement • 13 Nov 2024 20:30

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Exchange Announcement • 28 Oct 2024 20:22

Current Report (Form 8-K | Period ending 2024-10-24)

Exchange Announcement • 25 Oct 2024 20:13

Current Report (Form 8-K | Period ending 2024-10-25)

No more filings

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00